Next steps In-vitro and cellular testing hit compounds In-vivo testing for best leads Clinical Study phase I first Q1 2004 HTS for new hit compounds Transgenic rabbits dominant/negative and/or RNAi Polymorphism of other candidat genes Enhance the value of the company and reduce the risks to investors in order to attract Venture Capital
{}